94 The cytotoxic effects of 17-AAG, an inhibitor of Hsp90 are enhanced by combination with the PI-3-kinase inhibitor LY294002 in non-small cell lung cancer (NSCLC) cell lines

V.Papadimitrakopoulou; S.Angelaki; S.Lnu; E.Brown; G.Ayers

首页> 外文期刊>European Journal of Cancer Supplements >94 The cytotoxic effects of 17-AAG, an inhibitor of Hsp90 are enhanced by combination with the PI-3-kinase inhibitor LY294002 in non-small cell lung cancer (NSCLC) cell lines

【24h】

94 The cytotoxic effects of 17-AAG, an inhibitor of Hsp90 are enhanced by combination with the PI-3-kinase inhibitor LY294002 in non-small cell lung cancer (NSCLC) cell lines

机译：94 Hsp90抑制剂17-AAG与PI-3-激酶抑制剂LY294002联合在非小细胞肺癌（NSCLC）细胞系中的细胞毒性作用得到增强

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2004年第8期|共1页
作者
V.Papadimitrakopoulou; S.Angelaki; S.Lnu; E.Brown; G.Ayers;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Novel Hsp90 Inhibitor C086 Potently Inhibits Non-Small Cell Lung Cancer Cells As A Single Agent Or In Combination With Gefitinib [J] . Liman Wang, Yingjuan Fan, Hanhao Mei, Cancer Management and Research . 2019,第2期

机译：新型Hsp90抑制剂C086可单独或与吉非替尼联用有效抑制非小细胞肺癌细胞
2. Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cells [J] . Mi Zhang, Haitian Quan, Li Fu, Thoracic cancer. . 2021,第8期

机译：第三代EGFR抑制剂HS-10296与Famitinib组合，一种多目标酪氨酸激酶抑制剂，通过增强EGFR-突变体非小细胞肺癌细胞中的下游信号抑制来施加协同抗肿瘤效果
3. Histone deacetylase inhibitor romidepsin enhances anti-tumor effect of erlotinib in non-small cell lung cancer (NSCLC) cell lines. [J] . Zhang W, Peyton M, Xie Y, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2009,第2期

机译：组蛋白脱乙酰基酶抑制剂罗米地辛在非小细胞肺癌（NSCLC）细胞系中增强厄洛替尼的抗肿瘤作用。
4. EFFECTS OF CARVACROL ON A HUMAN NON-SMALL CELL LUNG CANCER (NSCLC) CELL LTNE, A549 [C] . A.Tansu Koparal, Melih Zeytinoglu Annual Meeting of the Japanese Association for Animal Cell Technology . 2003

机译：Carvacrol对人非小细胞肺癌（NSCLC）细胞LTNE，A549的影响
5. Enhancing the Therapeutic Effects of Low Doses of Ionizing Radiation in Non-Small Cell Lung Cancers Using a Combination of PARP Inhibitors and DNA Demethylating Agents. [D] . Biondi, Christopher Anthony. 2016

机译：使用PARP抑制剂和DNA去甲基化剂的组合增强非小细胞肺癌低剂量电离辐射的治疗效果。
6. Hsp90 inhibitors enhance the antitumoral effect of osimertinib in parental and osimertinib-resistant non-small cell lung cancer cell lines [O] . Jordi Codony-Servat, Santiago Viteri, Carles Codony-Servat, 2019

机译：Hsp90抑制剂可增强osimertinib在亲本和耐osimertinib的非小细胞肺癌细胞系中的抗肿瘤作用
7. >Novel Hsp90 Inhibitor C086 Potently Inhibits Non-Small Cell Lung Cancer Cells As A Single Agent Or In Combination With Gefitinib [O] . Liman Wang, Yingjuan Fan, Hanhao Mei, 2019

机译：>新型HSP90抑制剂C086易于抑制非小细胞肺癌细胞作为单一剂或与GEFITINIB的组合

94 The cytotoxic effects of 17-AAG, an inhibitor of Hsp90 are enhanced by combination with the PI-3-kinase inhibitor LY294002 in non-small cell lung cancer (NSCLC) cell lines

著录项

相似文献

相关主题

期刊订阅